Shijiazhuang Yiling Pharmaceutical Co. Ltd. | Ownership
Companies that own Shijiazhuang Yiling Pharmaceutical Co. Ltd.
First Seafront Fund Management Co., Ltd.
10,240,274
1.04%
10,240,274
0.52%
03/21/2018
CCB Principal Asset Management Co., Ltd.
10,074,876
1.02%
7,943,258
0.33%
03/21/2018
China Southern Asset Management Co., Ltd.
2,176,754
0.22%
-169,900
0.04%
12/31/2017
Guotai Asset Management Co., Ltd.
1,074,113
0.11%
-720,534
0.03%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
895,776
0.09%
-151,709
0.11%
12/31/2017
Changsheng Fund Management Co., Ltd.
792,868
0.08%
-373,600
0.08%
12/31/2017
GF Fund Management Co., Ltd.
488,011
0.05%
-14,700
0.01%
12/31/2017
SWS MU Fund Management Co., Ltd.
409,580
0.04%
-128,600
0.02%
12/31/2017
The Vanguard Group, Inc.
329,061
0.03%
0
0%
07/31/2018
Tian Hong Asset Management Co., Ltd.
158,979
0.02%
1,100
0.02%
12/31/2017
| Address |
No. 238 Tianshan Avenue
Shijiazhuang Hebei 050035
China
|
|
Employees
|
- |
| Website |
http://www.yiling.cn |
| Updated |
07/08/2019 |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the pharmaceutical manufacturing. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products. The company was founded by Yi Ling Wu in August 28, 2001 and is headquartered in Shijiazhuang, China. |
